Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: obtain (280), request (403)

CT colonography (with hyoscine butylbromide and intravenous contrast) - patient information

Description: This factsheet contains information and advice following a CT colonography (with hyoscine butylbromide and intravenous contrast).
Url: /Media/UHS-website-2019/Patientinformation/Scansandx-rays/CT-colonography-with-hyoscine-butylbromide-and-intravenous-contrast-2216-PIL.pdf

Cancer genetics referral form

Description: Wessex Clinical Genetics Service Please complete this form and submit on eRS to 7939141 Genetics - Cancer - (Triage) - Southampton - UHSFT - RHM - PA
Url: /Media/UHS-website-2019/Docs/Services/Genetics/Cancer-genetics/cancer-genetics-referral-form.doc

Botox injections for axillary hyperhidrosis - patient information

Description: This factsheet contains information about having Botox (botulinum toxin) injections for axillary hyperhidrosis (excessive sweating).
Url: /Media/UHS-website-2019/Patientinformation/Skin/Botox-injections-for-axillary-hyperhidrosis-2004-PIL.pdf

Annual report 15-16

Description: University Hospital Southampton NHS Foundation Trust Annual report and accounts 2015/16 incorporating the quality account 2015/16 Presented to Parliament
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/annual-report-15-16.pdf

DVdSC (weekly cycles 9 onwards) DaratumumabSC-Bortezomib-Dexamethasone Ver1

Description: Chemotherapy Protocol Myeloma DVd SC (weekly) Bortezomib Daratumumab Dexamethasone Cycles 9 onwards Regimen • Myeloma – Bortezomib with daratumumab and dexa
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVdSC-weekly-cycles-9-onwards-DaratumumabSC-Bortezomib-Dexamethasone-Ver1.pdf

MyelomaCTDa28CyclophosphamideDexamethasoneThalidomideAttenuated(CTDa)Ver1

Description: Chemotherapy Protocol MULTIPLE MYELOMA CTDa (28)-CYCLOPHOSPHAMIDE-DEXAMETHASONE-THALIDOMIDE (ATTENUATED) (CTDa-28) T
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/MyelomaCTDa28CyclophosphamideDexamethasoneThalidomideAttenuatedCTDaVer1.pdf

MyelomaCTD21CyclophosphamideDexamethasoneThalidomide(CTD)Ver1

Description: Chemotherapy Protocol MULTIPLE MYELOMA CTD (21)-CYCLOPHOSPHAMIDE-DEXAMETHASONE-THALIDOMIDE (21 days) There are multi
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/MyelomaCTD21CyclophosphamideDexamethasoneThalidomideCTDVer1.pdf

Head injury - patient information

Description: This factsheet contains information that you and your family or carers may find useful after your head injury.
Url: /Media/UHS-website-2019/Patientinformation/Generalmedicine/Headinjury-1709-PIL.pdf

Eye injuries in children - patient information

Description: This factsheet highlights some of the common causes of eye injuries, ways to prevent eye injuries and what you can do
Url: /Media/UHS-website-2019/Patientinformation/Eyes/Eye-injuries-in-children-2362-PIL.PDF

Passing patient information to the police

Description: In what circumstances should medical professionals pass confidential information to the police?
Url: /HealthProfessionals/Clinical-law-updates/Passing-patient-information-to-the-police.aspx

111 to 120 of 565

Previous … 10 11 12 13 14 … Next